Coffee with Coker

The episode provides practical operational guidance on modifier 25 documentation requirements with specific examples (preventive visits, lesion removal, steroid injections, urgent care lacerations), but relies heavily on repeating foundational definitions and the host's personal opinions rather than introducing novel frameworks or counterintuitive insights. The core substance - separable work must be documented outside the surgical package - is well-established coding doctrine, not breakthrough thinking.

“the definition, the Wordy definition that we are given is a significant, separately identifiable E& M service by the same physician on the same day of the procedure or other therapeutic service”

“we have a nice little list of what is typically associated with a procedure and would not be included in with that separate E& M”

The episode applies standard modifier 25 rules to common scenarios but offers little contrarian or first-principles thinking. The hosts acknowledge their positions as 'opinions' and that payers interpret rules differently, which is honest but not original. The discussion of steroid injection re-dosing and medication changes attempts some nuance but doesn't fundamentally challenge existing interpretation or propose novel frameworks.

“Because insurance companies have different opinions on what is appropriate and what's not, and nothing is consistent across the board”

“this is an opinionated modifier and therefore we get ourselves very wrapped up and very confused”

Erika is presented as an experienced auditor with real client case experience (blood thinner patient, cerumen removal scheduling patterns), and Jaci demonstrates practitioner knowledge from audit work. Both speakers have concrete operational experience rather than purely theoretical credentials. However, neither is positioned as a senior healthcare executive or major health system leader, limiting the seniority caliber for a B2B operator seeking strategic insight.

“That is an example that I just had with a client is that patient was, you know, an older patient who recently started blood thinners and came in for a laceration that would not stop bleeding”

“I've been doing a lot of ENT and a lot of Medicare patients just have it scheduled”

The episode includes concrete scenario examples (preventive visit with additional concerns, lesion removal with rash, steroid injection re-dosing, laceration with bleeding disorder, cerumen removal) and references specific documentation elements (medication lists, problem assessment statements). However, it lacks quantified data - no claims denial rates, payment impact figures, or statistical prevalence of modifier 25 misuse. The AMA's CPT modifier reporting document is referenced but not deeply cited with specific rules.

“patient comes in for a scheduled lesion removal, and at the same time, notice, they have now developed a rash”

“older patient who recently started blood thinners and came in for a laceration that would not stop bleeding”

Jaci asks open-ended follow-up questions ('Why is this still such a problem?', 'What do you think?') and the hosts actively disagree on interpretation (e.g., time-based billing caveats, well-visit documentation standards), which creates productive tension. However, the conversation frequently loops back to abstract principles ('it depends on documentation') without pushing for resolution or testing claims empirically. Few hostile or genuinely challenging questions that would force deeper justification.

“But there's a lot of things that aren't included as well. So, it doesn't make anything easy, but at least we have a definition to work with”

“I agree. And it makes sense, and I think I would like to just comment right now that if anyone's listening to this podcast or watching the podcast and has comments or things, please send us back some information”